Amniotic Membrane Transplantation: Clinical Applications in Enhancing Wound Healing and Tissue Regeneration DOI
Mutali Musa, Ekele Chukwuyem, Ehimare Enaholo

et al.

Advances in experimental medicine and biology, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 1, 2024

Language: Английский

Development of injectable hyaluronic acid-based hydrogels with antioxidant activity for the treatment of corneal neovascularization DOI
Linyu Long, Zhengwei Ge, Fanjun Zhang

et al.

Chemical Engineering Journal, Journal Year: 2023, Volume and Issue: 478, P. 147147 - 147147

Published: Nov. 7, 2023

Language: Английский

Citations

9

Composite nano hydrogel with dual response and hierarchical drug release for enhanced wound healing DOI Creative Commons
Lei Zhang,

Panyong Zhu,

Bei Zhao

et al.

Materials & Design, Journal Year: 2024, Volume and Issue: 239, P. 112805 - 112805

Published: Feb. 27, 2024

A novel nanocomposite hydrogel with photothermal therapeutic properties, which could enhance the healing of surgical wounds, was developed. The composite comprises functionalized silica nanoparticles (FSNs) loaded desferoxamine (DFO) as core and a dexamethasone (Dex) filled hyaluronic acid–chitosan (HA-CS) shell. Dex can effectively control inflammation at wound site, DFO is beneficial in proliferating skin cells. two drugs promote site. aim this approach to demonstrate hierarchical continuous release from FSNs@DFO-H@Dex system reduce healing. Furthermore, controlled be achieved by controlling near-infrared illumination. nano has response, accelerates reducing through regulating immunological response damaged tissue.

Language: Английский

Citations

3

Incorporation of GelMA/PEGDA into the Decellularized Cornea as a Potential Hybrid Scaffold for In Situ Repairing of Deep Anterior Corneal Defects DOI

Elham Hamedi,

Safieh Boroumand,

Faraz Sigaroodi

et al.

Journal of Polymers and the Environment, Journal Year: 2024, Volume and Issue: 32(9), P. 4763 - 4776

Published: April 27, 2024

Language: Английский

Citations

2

Latest advances in hydrogel therapy for ocular diseases DOI

Jiaxi Han,

Haozhou Shu,

Ling Zhang

et al.

Polymer, Journal Year: 2024, Volume and Issue: 306, P. 127207 - 127207

Published: May 25, 2024

Language: Английский

Citations

2

Differentiation of Human Mesenchymal Stem Cells into Corneal Epithelial Cells: Current Progress DOI Creative Commons
Abdul Malik Setiawan, Taty Anna Kamarudin

Current Issues in Molecular Biology, Journal Year: 2024, Volume and Issue: 46(12), P. 13281 - 13295

Published: Nov. 21, 2024

The limited availability of corneal tissue grafts poses significant challenges in the treatment blindness. Novel utilizes stem cell transplanted from healthy side cornea to damaged side. However, this procedure is only possible for those who have one-sided Human cells offer promising potential engineering, providing an alternative solution. Among different types cells, mesenchymal (MSCs) stand out due their abundance and ease isolation. MSCs can be derived bone marrow, adipose, umbilical cord tissues. Differentiating MSC toward achieved through several methods including chemical induction co-culture with adult such as human limbal epithelial (LESCs) (hTCEpi). Adipose-derived (ADSCs) are most common type that has been studied differentiation. Corneal targeted by researchers Chemical small molecules, especially morphogenetic protein 4 (BMP4), all-trans retinoic acid (ATRA), epidermal growth factor (EGF), gained more popularity This review highlights current progress utilizing differentiation studies, showcasing revolutionize treatments

Language: Английский

Citations

2

Gelatin nanofibers coated with hyaluronic acid as a mesenchymal stromal cell scaffold for corneal regeneration DOI
Gisele Rodrigues da Silva,

Euisun Song,

Karen Chen

et al.

International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: unknown, P. 125009 - 125009

Published: Nov. 1, 2024

Language: Английский

Citations

2

Advanced bioengineering strategies broaden the therapeutic landscape for corneal failure DOI Creative Commons

Reem Al Monla,

Vincent Daïen, Frédéric Michon

et al.

Frontiers in Bioengineering and Biotechnology, Journal Year: 2024, Volume and Issue: 12

Published: Nov. 13, 2024

The cornea acts as the eye foremost protective layer and is essential for its focusing power. Corneal blindness may arise from physical trauma or conditions like dystrophies, keratitis, keratoconus, ulceration. While conventional treatments involve medical therapies donor allografts—sometimes supplemented with keratoprostheses—these options are not suitable all corneal defects. Consequently, development of bioartificial tissue has emerged a critical research area, aiming to address global shortage human donors. Bioengineered corneas hold considerable promise substitutes, potential replace either specific layers entire thickness damaged corneas. This review first delves into structural anatomy cornea, identifying key attributes necessary successful bioengineering. It then examines various pathologies, current treatments, their limitations. Finally, outlines primary approaches in engineering, exploring cell-free, cell-based, scaffold-based three emerging strategies failure.

Language: Английский

Citations

2

Reversed Corneal Fibroblasts Therapy Restores Transparency of Mouse Cornea after Injury DOI Open Access
М. А. Суровцева, K. Yu. Krasner, I. I. Kim

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(13), P. 7053 - 7053

Published: June 27, 2024

Cell-based therapies using corneal stromal stem cells (CSSC), keratocytes, or a combination of both suppress scarring. The number quiescent keratocytes in the cornea is small; it difficult to expand them vitro quantities suitable for transplantation. This study examined therapeutic effect fibroblasts reversed into (rCF) mouse model mechanical injury. rCF was studied vivo (slit lamp, optical coherence tomography) and ex (transmission electron microscopy immunofluorescence staining). Injection injured accompanied by recovery thickness, improvement transparency, reduction type III collagen stroma, absence myofibroblasts, structural organization fibers. TEM results showed that 2 months after intrastromal injection cells, there decrease fibril density an increase diameter average distance between fibrils. fibrils were well ordered maintained short-range order nearest-neighbor fibrils, although averaged increased. Our demonstrated cell therapy from ReLEx SMILe lenticules promotes transparent stroma

Language: Английский

Citations

1

Innovative Bioscaffolds in Stem Cell and Regenerative Therapies for Corneal Pathologies DOI Creative Commons

F Visalli,

Federico Fava,

Matteo Capobianco

et al.

Bioengineering, Journal Year: 2024, Volume and Issue: 11(9), P. 859 - 859

Published: Aug. 23, 2024

Corneal diseases, which can result in substantial visual impairment and loss of vision, are an important worldwide health issue. The aim this review was to investigate the novel application bioscaffolds stem cell regenerative treatments for treatment corneal disorders. current literature reports that organic artificial substances create imitate inherent structure cornea, facilitating attachment, growth, specialization cells. Sophisticated methods such as electrospinning, 3D bioprinting, surface modification have been reported enhance characteristics scaffold. These shown greatly improve survival cells facilitate regrowth tissue both laboratory live animal experiments. In addition, incorporation growth factors bioactive compounds within scaffolds promote a favorable milieu regeneration. To summarize, advancement these groundbreaking presents hopeful strategy regeneration has potential results individuals suffering from This study highlights possibility utilizing fields biomaterials science tackle medical demands not yet satisfied field ophthalmology.

Language: Английский

Citations

1

In Situ UNIversal Orthogonal Network (UNION) Bioink Deposition for Direct Delivery of Corneal Stromal Stem Cells to Corneal Wounds DOI
Lucia G. Brunel, Betty Cai, Sarah M. Hull

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 24, 2024

ABSTRACT The scarcity of human donor corneal graft tissue worldwide available for transplantation necessitates the development alternative therapeutic strategies treating patients with blindness. Corneal stromal stem cells (CSSCs) have potential to address this global shortage by allowing a single cornea treat multiple patients. To directly deliver CSSCs defects within an engineered biomatrix, we developed UNIversal Orthogonal Network (UNION) collagen bioink that crosslinks in situ bioorthogonal, covalent chemistry. This cell-gel therapy is optically transparent, stable against contraction forces exerted CSSCs, and permissive efficient growth epithelial cells. Furthermore, remain viable UNION gel precursor solution under standard storage transportation conditions. approach promoted transparency re-epithelialization rabbit anterior lamellar keratoplasty model, indicating serves effectively as -forming, suture-free delivering wounds. TEASER. are delivered chemically crosslinked regenerative biomaterial therapy.

Language: Английский

Citations

1